BioCentury
ARTICLE | Company News

Management tracks

March 2, 2017 1:14 AM UTC

Inflammatory and neurological disease company Forward Pharma A/S (NASDAQ:FWP) promoted Claus Svendsen to CEO from EVP. He replaces Peder Andersen, who will remain Forward's COO until Sept. 1.

The WuXi NextCODE genomics unit of New WuXi Life Science Ltd. (Shanghai, China) promoted Hannes Smarason to CEO from COO. The unit also named John Long CFO and Alex Fowkes COO. Long was SVP of finance and Fowkes was SVP of commercial operations at the parent company's WuXi AppTec unit...